Elsevier

Vaccine

Volume 11, Issue 5, March 1993, Pages 578-581
Vaccine

Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination

https://doi.org/10.1016/0264-410X(93)90236-QGet rights and content

Abstract

Meningococcal meningitis is still a serious infectious disease with a mortality rate that can be as high as 10% even in developed countries. Military recruits are generally a high-risk group for meningococcal disease, with a reported incidence of four to ten times greater than that of the general population. In Italy the results of the National Meningitis Surveillance Programme showed a high attack rate of the disease among recruits in 1985 as well as in 1986, with 92 and 95% of the cases, respectively, caused by serogroup C and thus preventable. These findings led to the authorities' decision to make vaccination against meningococcal disease mandatory for recruits starting from January 1987. After almost 5 years from the introduction of meningococcal vaccination, we here sum up the epidemiological and immunological effects of the vaccination. From the epidemiological point of view we have observed a dramatic reduction of the prevalence of the disease. In 1987, the year in which we had 150 000 unvaccinated and 150 000 vaccinated recruits, the protective efficacy was 91.2%. From the immunological point of view, vaccination is highly effective, as seroconversion against polysaccharide (PS) A and C is 84 and 91%, respectively. The spectrotypic analysis of the sera before and after vaccination shows that the type of response is mainly oligoclonal, like the majority of the responses to PSs, and the antibodies induced by a sole PS are not qualitatively different from the antibodies induced by natural immunization. In addition, the efficacy is not modified by environmental factors like hypoxia, as demonstrated during permanence at 16 174 feet for 20 days. In conclusion, the anti-meningococcal PSA and PSC vaccine can be seen as a very safe and effective method of controlling the spread of the disease in military recruits since its efficacy is very high, considering approximately 90% of the subjects develop a protective response, it is safe and is proven to provide satisfactory immunological response even under unfavourable conditions, like hypobaric hypoxia.

References (14)

There are more references available in the full text version of this article.

Cited by (46)

  • Preventive effect of meningococcal vaccination in Israeli military recruits

    2010, American Journal of Infection Control
    Citation Excerpt :

    The expanding armamentarium of vaccines against the various serotypes of the bacteria may contribute to better prevention of this devastating disease in crowded population and not only military personnel. Our results are consistent with the findings of studies in the armed forces of Italy13 and Canada.14 In Italy, the immunization program for military personnel was prompted by findings of a high incidence of serogroup C disease, and it proved to have a high protective efficacy, both epidemiologically and in terms of immunologic response (90% and 91%, respectively).

  • Complement C7 deficiency presenting as recurrent aseptic meningitis

    2004, Annals of Allergy, Asthma and Immunology
View all citing articles on Scopus

To whom correspondence should be addressed.

View full text